S&P 500
(0.91%) 5 064.20 points
Dow Jones
(0.85%) 38 226 points
Nasdaq
(1.51%) 15 841 points
Oil
(0.08%) $79.06
Gas
(5.02%) $2.03
Gold
(0.10%) $2 313.40
Silver
(0.68%) $26.93
Platinum
(0.85%) $963.00
USD/EUR
(-0.07%) $0.932
USD/NOK
(-0.26%) $11.00
USD/GBP
(-0.05%) $0.798
USD/RUB
(-2.30%) $91.12

实时更新: Smith & Nephew SNATS Inc. [SNN]

交易所: NYSE 部门: Healthcare 工业: Medical - Devices
最后更新时间3 May 2024 @ 04:00

1.24% $ 24.44

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 04:00):
Profile picture for Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
今日成交量 1.30M
平均成交量 954 109
市值 10.66B
EPS $0 ( 2024-02-27 )
下一个收益日期 ( $0 ) 2024-08-01
Last Dividend $0.288 ( 2023-10-05 )
Next Dividend $0 ( N/A )
P/E 40.73
ATR14 $0.0120 (0.05%)

音量 相关性

長: -0.71 (moderate negative)
短: 0.18 (neutral)
Signal:(40.774) Neutral

Smith & Nephew SNATS Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Smith & Nephew SNATS Inc. 相关性 - 货币/商品

The country flag 0.37
( neutral )
The country flag 0.14
( neutral )
The country flag 0.00
( neutral )
The country flag 0.61
( weak )
The country flag -0.38
( neutral )
The country flag 0.06
( neutral )

Smith & Nephew SNATS Inc. 财务报表

Annual 2023
营收: $5.55B
毛利润: $3.70B (66.70 %)
EPS: $0.600
FY 2023
营收: $5.55B
毛利润: $3.70B (66.70 %)
EPS: $0.600
FY 2022
营收: $5.22B
毛利润: $3.70B (70.85 %)
EPS: $0.510
FY 2021
营收: $5.21B
毛利润: $3.67B (70.40 %)
EPS: $1.196

Financial Reports:

No articles found.

Smith & Nephew SNATS Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.288
(N/A)
$0
(N/A)
$0.462
(N/A)
$0
(N/A)
$0
(N/A)
$0.288
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Smith & Nephew SNATS Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.94 - Stable (18.86%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.139 2000-05-04
Last Dividend $0.288 2023-10-05
Next Dividend $0 N/A
Payout Date 2023-11-01
Next Payout Date N/A
# dividends 48 --
Total Paid Out $10.43 --
Avg. Dividend % Per Year 1.50% --
Score 4.56 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.94
Div. Directional Score 8.27 --
Next Divdend (Est)
(2024-09-30)
$0.288 Estimate 7.53 %
Dividend Stability
0.30 Poor
Dividend Score
4.56
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2000 $0.194 2.88%
2001 $0.146 1.58%
2002 $0.154 1.28%
2003 $0.169 1.36%
2004 $0.184 1.10%
2005 $0.194 0.96%
2006 $0.204 1.08%
2007 $0.223 1.07%
2008 $0.247 1.07%
2009 $0.271 2.08%
2010 $0.299 1.45%
2011 $0.328 1.56%
2012 $0.414 2.12%
2013 $0.532 2.39%
2014 $0.560 1.98%
2015 $0.608 1.69%
2016 $0.626 1.80%
2017 $0.616 2.05%
2018 $0.734 2.10%
2019 $0.728 2.00%
2020 $0.750 1.55%
2021 $0.750 1.75%
2022 $0.750 2.14%
2023 $0.750 2.75%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50
SRV Dividend Royal 2023-12-04 Monthly 18 7.53% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04751.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05021.500-0.553-0.830[0.1 - 1]
payoutRatioTTM1.247-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.6790.800-0.709-0.567[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.294-1.5005.09-7.64[0 - 0.6]
interestCoverageTTM5.491.0009.089.08[3 - 30]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
freeCashFlowPerShareTTM0.4122.009.7910.00[0 - 20]
debtEquityRatioTTM0.564-1.5007.75-10.00[0 - 2.5]
grossProfitMarginTTM0.6881.0001.8621.862[0.2 - 0.8]
operatingProfitMarginTTM0.1371.0009.259.25[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2051.0009.979.97[0.2 - 2]
assetTurnoverTTM0.5530.8009.647.72[0.5 - 2]
Total Score10.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.121.0006.050[1 - 100]
returnOnEquityTTM0.05022.50-0.356-0.830[0.1 - 1.5]
freeCashFlowPerShareTTM0.4122.009.8610.00[0 - 30]
dividendYielPercentageTTM3.111.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
payoutRatioTTM1.2471.50010.00-10.00[0 - 1]
pegRatioTTM1.5501.5003.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1091.0009.770[0.1 - 0.5]
Total Score5.94

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。